Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
published in: The New England Journal of Medicine
date of publication: 2015-10-01
language: English
main subject: multiple sclerosis
Cites articles
There is nothing here
Article - wd:Q40962718